Related Experiment Videos
Microembolism in Carotid Artery Disease
Mario Siebler1, Matthias Sitzer, Georg Rose
1Department of Neurology, Heinrich-Heine-University, Moorenstrasse 5, P.O. Box 101007, D-40001 Düsseldorf, Germany.
Echocardiography (Mount Kisco, N.Y.)
|September 1, 1996
Summary
Clinically silent cerebral microemboli, detected by transcranial Doppler (TCD) sonography, are more frequent in symptomatic patients with carotid artery stenosis. Detecting these microembolic signals may indicate unstable carotid artery disease.
Area of Science:
- Neurology
- Vascular Medicine
- Medical Imaging
Background:
- Abnormal high-intensity transient signals on transcranial Doppler (TCD) sonography are linked to cerebral microembolism.
- These microembolic events are often clinically silent but detectable with long-term TCD monitoring in cerebrovascular disease patients.
Purpose of the Study:
- To investigate the occurrence and significance of clinically silent cerebral microemboli in patients with internal carotid artery (ICA) stenosis.
- To explore the potential of detecting microemboli as an indicator of unstable carotid artery disease.
Main Methods:
- Utilized long-term transcranial Doppler (TCD) monitoring to detect high-intensity transient signals (microemboli).
- Compared the frequency of microembolic events in neurologically symptomatic versus asymptomatic patients with high-grade ICA stenosis.
Main Results:
- Microembolic events occurred significantly more frequently downstream of high-grade ICA stenosis in neurologically symptomatic patients compared to asymptomatic ones.
- The rate of microemboli, while random, exhibits circadian fluctuations and declines in the weeks following an ischemic event.
- Pathoanatomic studies suggest luminal ulcer and thrombosis in the stenosed ICA are primary sources of microemboli.
Conclusions:
- Detection of clinically silent cerebral microembolism via TCD sonography provides paraclinical evidence of unstable carotid artery disease.
- This detection method may aid in evaluating and developing more specific treatment strategies for cerebrovascular disease.